𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Generic competition and market exclusivity periods in pharmaceuticals

✍ Scribed by Henry G. Grabowski; Margaret Kyle

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
170 KB
Volume
28
Category
Article
ISSN
0143-6570

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

In this paper we examine generic competition and market exclusivity periods for pharmaceuticals experiencing their initial generic entry between 1995 and 2005. We find that generic competition has increased over several dimensions. First, an increasing number of drugs are subject to generic entry, including drugs with relatively modest annual average sales. Second, drugs with larger sales attract more generic entrants and have shorter market exclusivity periods than smaller selling drugs. Third, blockbuster drugs with annual sales in excess of $1 billion have experienced significant decreases in their market exclusivity periods in recent years. We also find that Hatch‐Waxman Act patent challenges have negatively affected market exclusivity periods over the 1995 to 2005 period. Copyright Β© 2007 John Wiley & Sons, Ltd.

πŸ“œ SIMILAR VOLUMES

Entry and competition in generic biologi
Entry and competition in generic biologics
✍ Henry G. Grabowski; David B. Ridley; Kevin A. Schulman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 189 KB

## Abstract Patents for several blockbuster biological products are expected to expire soon. The Food and Drug Administration is examining whether biologics can and should be treated like pharmaceuticals with regard to generics. In contrast with pharmaceuticals, which are manufactured through chemi

Product innovation, product–market compe
Product innovation, product–market competition and persistent profitability in the U.S. pharmaceutical industry
✍ Peter W. Roberts πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

Increasingly, strategy scholars are exploring the relationships between innovation, competition, and the persistence of superior profits. Sustained high profitability may result when a firm repeatedly introduces valuable innovations that service previously unmet consumer demands. While the returns t

DOMESTIC MARKETS AND INTERNATIONAL COMPE
DOMESTIC MARKETS AND INTERNATIONAL COMPETITIVENESS: GENERIC AND PRODUCT-SPECIFIC COMPETENCIES IN THE ENGINEERING SECTOR
✍ ASHISH ARORA; ALFONSO GAMBARDELLA πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 820 KB

This paper develops a theory of how the size of the domestic market shapes firm competencies. Our theory implies that large markets are beneficial even if factors such as economies of scale or learning effects are absent. We validate our model by an international comparison of the performance of fir

Competition in the Japanese wholesale po
Competition in the Japanese wholesale potato market
✍ Yusuke Higaki; Kisan Gunjal; Garth Coffin πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 1 views

## Abstract The Japanese potato market is characterized by regional domination of production and marketing by strong cooperatives exhibiting a high degree of concentration with potential oligopolistic market power. In this research, the level of competition in the Japanese potato market was evaluat

Competition between brand-name and gener
Competition between brand-name and generics – analysis on pricing of brand-name pharmaceutical
✍ Ying Kong πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 397 KB

## Abstract The objective of this paper is to provide two‐stage game models explaining the β€˜Generic Competition Paradox’ that demonstrates an increase of brand‐name drug price in response to generic entry. Under the assumption that there are two groups of consumers who are segmented by their insura